0001209191-24-002928.txt : 20240206
0001209191-24-002928.hdr.sgml : 20240206
20240206175614
ACCESSION NUMBER: 0001209191-24-002928
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adler Eric
CENTRAL INDEX KEY: 0001994972
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 24601478
MAIL ADDRESS:
STREET 1: C/O LEXEO THERAPEUTICS, INC.
STREET 2: 345 PARK AVENUE SOUTH, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001907108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 854012572
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (212) 547-9879
MAIL ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-02
0
0001907108
Lexeo Therapeutics, Inc.
LXEO
0001994972
Adler Eric
C/O LEXEO THERAPEUTICS, INC.
345 PARK AVENUE SOUTH, FLOOR 6
NEW YORK
NY
10010
0
1
0
0
Chief Medical Officer
0
Common Stock
2024-02-02
4
A
0
26875
0.00
A
26875
D
Employee Stock Option (right to buy)
17.00
2024-02-02
4
A
0
161250
0.00
A
2034-02-01
Common Stock
161250
161250
D
The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
25% of the shares underlying the option vest and become exercisable on February 2, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
/s/ Jenny Robertson, attorney-in-fact
2024-02-06